Pfizer: A Quietly Outperforming High-Dividend Idea, Pipeline On Watch (Upgrade)
Pfizer delivered a Q2 double beat, raised full-year revenue guidance, and benefits from pipeline progress. Read why PFE stock is a Buy.
seekingalpha.com
Positive 100%
PFE
+0.68%